Cited by 407Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesReceptor Mechanisms and Signaling

Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction

Open access
Nicholson, Sandra E., Willson, Tracy A., Farley, Alison, Starr, Robyn, Zhang, Jian‐Guo, Baca, Manuel, Alexander, Warren S., Metcalf, Donald +2 more·1999·The EMBO Journal

Abstract

SOCS-1 (suppressor of cytokine signaling-1) is a representative of a family of negative regulators of cytokine signaling (SOCS-1 to SOCS-7 and CIS) characterized by a highly conserved C-terminal SOCS box preceded by an SH2 domain. This study comprehensively examined the ability of several SOCS family members to negatively regulate the gp130 signaling pathway. SOCS-1 and SOCS-3 inhibited both interleukin-6 (IL-6)- and leukemia inhibitory factor (LIF)-induced macrophage differentiation of murine monocytic leukemic M1 cells and LIF induction of a Stat3-responsive reporter construct in 293T fibroblasts. Deletion of amino acids 51-78 in the N-terminal region of SOCS-1 prevented inhibition of LIF signaling. The SOCS-1 and SOCS-3 N-terminal regions were functionally interchangeable, but this did not extend to other SOCS family members. Mutation of SH2 domains abrogated the ability of both SOCS-1 and SOCS-3 to inhibit LIF signal transduction. Unlike SOCS-1, SOCS-3 was unable to inhibit JAK kinase activity in vitro, suggesting that SOCS-1 and SOCS-3 act on the JAK-STAT pathway in different ways. Thus, although inhibition of signaling by SOCS-1 and SOCS-3 requires both the SH2 and N-terminal domains, their mechanisms of action appear to be biochemically different.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emboj/18.2.375

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SOCS1 and SOCS3 proteins can both inhibit JAK phosphorylation of STAT, creating a negative feedback loop that attenuates cytokine signal transduction.

    “SOCS1 and SOCS3 proteins can both inhibit JAK phosphorylation of STAT, thus creating a negative feedback loop that attenuates cytokine signal transduction, although the mechanisms by which they act appear to differ.”

    From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [20]

    The section on STAT3 tyrosine phosphorylation reports that both SOCS-1 and SOCS-3 inhibit LIF-induced STAT3 phosphorylation in M1 cells. The Introduction describes a negative feedback loop for SOCS-1 only, not SOCS-3; the discussion (p. 382) also says SOCS-3 did not directly inhibit JAK kinase activity in the assay. Thus the shared reduction in STAT3 phosphorylation is supported, but a negative feedback loop for both proteins—and direct JAK inhibition by both—is not established. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • SOCS3 inhibits signaling by binding to phosphorylated tyrosine sites on the cytoplasmic domain of the receptor.

    “Whereas SOCS1 functions by binding directly to JAK proteins, SOCS3 inhibits signaling by binding to phosphorylated tyrosine sites on the cytoplasmic domain of the receptor (19,20).”

    From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [20]

    The discussion (p. 382) says SOCS-3 inhibits IL-6 and LIF signaling, but presents binding to receptor phosphotyrosine residues as one possible mechanism, not an established one. The citing sentence states that mechanism as fact. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • SOCS1 functions by binding directly to JAK proteins.

    “Whereas SOCS1 functions by binding directly to JAK proteins, SOCS3 inhibits signaling by binding to phosphorylated tyrosine sites on the cytoplasmic domain of the receptor (19,20).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 4

  1. Chen,M. et al. (1997) The amino terminus of JAK3 is necessary and sufficient for binding to the common γ chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl Acad. Sci. USA, 94, 6910-6915.
  2. Hilton,D.J. et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl Acad. Sci. USA, 95, 114-119.
  3. MacGregor,G.R., Nolan,G.P., Fiering,S., Roederer,M. and Herzenberg,L.A. (1991) Use of E.coli lacZ (β-galactosidase) as a reporter gene. In Murray,E.J. (ed.), Methods in Molecular Biology: Gene Transfer and Expression Protocols. The Humana Press Inc., Clifton, NJ, pp. 217-235.
  4. Metcalf,D. (1984) Hemopoietic Colony-stimulating Factors. Elsevier, Amsterdam.

Cited by

Sorted by citations

Authors
Nicholson, S. E., Willson, T. A., Farley, A., Starr, R., Zhang, J., Baca, M., Alexander, W. S., Metcalf, D., Hilton, D. J., & Nicola, N. A.
Affiliations
Walter and Eliza Hall Institute of Medical Research (AU)
Corresponding author
Nicholson, Sandra E.
Venue
The EMBO Journal
Published
1999-01-15
Volume
18
Issue
2
Pages
375-385
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W1967486091
Cited by
407
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 9 · 2016: 4 · 2015: 7 · 2014: 8 · 2013: 12 · 2012: 22
FWCI
16.54
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Australian Government
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council
  • National Cancer Institute (CA22556)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
SOCS1, SOCS3, suppressor of cytokine signaling, SOCS box, SH2 domain, LIF signaling, IL-6 signaling, gp130, JAK/STAT signaling, macrophage differentiation, STAT3, negative regulation of cytokine signaling, N-terminal domain
MeSH terms
Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Animals, Carrier Proteins, Cell Differentiation, Cell Line, DNA-Binding Proteins, Growth Inhibitors, Lymphokines, Mutation, Phosphorylation, Proteins, Repressor Proteins, Transcription Factors, Transfection, Tyrosine, Signal Transduction, Trans-Activators, Interleukin-6, Cytokines, Calcium-Calmodulin-Dependent Protein Kinases, src Homology Domains, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, Suppressor of Cytokine Signaling Proteins, Mice, Leukemia Inhibitory Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review